Movement Alert|QingSong Health Falls 8.02% in Regular Trading, Stock Breaks Below Previous Days Buyback Price Range Amid Lock-Up Expiry Concerns

Market Focus06-30 10:00

On June 30, QingSong Health (02661.HK) declined 8.02% in regular trading, trading at HKD 12.16/share, with turnover of HKD 20.28 million. The stock price has sharply broken below the company's June 29 buyback price range of HKD 13.47–14.51.

Despite multiple supportive measures — including a HKD 100 million share buyback plan announced on June 22, controlling shareholder Yang Yin's voluntary lock-up extension to January 1, 2027, and an actual repurchase of 700,000 shares for approximately HKD 9.95 million on June 29 — market selling pressure remains unrelieved. The key overhang is the expiry of the 6-month post-IPO lock-up period around June 30, with approximately 43 million shares from cornerstone investors and controlling shareholders becoming eligible for sale, representing over 20% of total equity.

Within the Health Care Services sector, the overall sector weakened. Among individual stocks, HEALTHYWAY INC down 3.78%, JXR down 2.99%, UNI MEDICAL down 1.12%, SOFTMEDX-NEW down 0.81%, GUSHENGTANG up 0.15%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment